Al­ny­lam, Sanofi flag an­oth­er promis­ing step for­ward for PhI­II he­mo­phil­ia drug

Al­ny­lam $AL­NY and its part­ners at Sanofi $SNY say their he­mo­phil­ia drug fi­tusir­an has tak­en a promis­ing step for­ward in the clin­ic, clear­ing an­oth­er leg …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.